For Medical Information or to report an adverse event, please select from the drop down menu or call (877) 660-6263 and select option ’2′
Exeltis USA is continuously evaluating business development opportunities:
The Exeltis USA business development team is prepared to work closely
with potential partners to structure transactions and strategies that are valuable to both parties.
Exeltis USA has an active, acutely focused business development
strategy, and, as a result, routinely evaluates new licensing, acquisition
and product development opportunities. Exeltis USA believes that its
commitment to commercializing new technologies, along with the
versatility of its existing drug delivery platforms, will continue to result
in a well-stocked, ever-maturing drug product pipeline.